BRPI0917554A2 - agente de tratamento ou agente de prevenção para oesteoartrite - Google Patents
agente de tratamento ou agente de prevenção para oesteoartriteInfo
- Publication number
- BRPI0917554A2 BRPI0917554A2 BRPI0917554A BRPI0917554A BRPI0917554A2 BR PI0917554 A2 BRPI0917554 A2 BR PI0917554A2 BR PI0917554 A BRPI0917554 A BR PI0917554A BR PI0917554 A BRPI0917554 A BR PI0917554A BR PI0917554 A2 BRPI0917554 A2 BR PI0917554A2
- Authority
- BR
- Brazil
- Prior art keywords
- agent
- westward
- arthritis treatment
- prevention
- treatment agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008199232 | 2008-08-01 | ||
PCT/JP2009/003668 WO2010013498A1 (ja) | 2008-08-01 | 2009-07-31 | 変形性関節症治療剤又は予防剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0917554A2 true BRPI0917554A2 (pt) | 2017-06-20 |
Family
ID=41610208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0917554A BRPI0917554A2 (pt) | 2008-08-01 | 2009-07-31 | agente de tratamento ou agente de prevenção para oesteoartrite |
Country Status (10)
Country | Link |
---|---|
US (1) | US8377444B2 (pt) |
EP (1) | EP2322220B1 (pt) |
JP (1) | JP4560822B2 (pt) |
KR (1) | KR101196514B1 (pt) |
CN (2) | CN102170905B (pt) |
AU (1) | AU2009277824B2 (pt) |
BR (1) | BRPI0917554A2 (pt) |
CA (1) | CA2732715C (pt) |
RU (1) | RU2492871C2 (pt) |
WO (1) | WO2010013498A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130011407A1 (en) * | 2010-01-29 | 2013-01-10 | Axis Inc. | Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
US9200077B2 (en) | 2010-01-29 | 2015-12-01 | Axis, Inc. | Injectable solution containing therapeutic agent for osteoarthritis |
JP2012246222A (ja) * | 2010-01-29 | 2012-12-13 | Axis Inc | 変形性関節症治療剤または予防剤を製造するための使用 |
WO2012043634A1 (ja) | 2010-09-29 | 2012-04-05 | 株式会社エヌビィー健康研究所 | ヒトプロスタグランジンe2受容体ep4に対する抗体 |
JP2012219022A (ja) * | 2011-04-05 | 2012-11-12 | Mss:Kk | 抗体を有効成分として含む血友病の治療剤 |
PL3247728T3 (pl) | 2015-01-20 | 2020-11-16 | Igm Biosciences, Inc. | Cząsteczki wiążące receptor nadrodziny czynnika martwicy nowotworów (TNF) i ich stosowanie |
RU2582974C1 (ru) * | 2015-06-01 | 2016-04-27 | Федеральное бюджетное учреждение "Государственный институт лекарственных средств и надлежащих правил" (ФБУ "ГИЛС и НП") | Комбинированная активная композиция для лечения заболеваний опорно-двигательного аппарата |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3023237C2 (de) * | 1980-06-21 | 1983-03-10 | Smit Ovens Nijmegen B.V., Nijmegen | Vorrichtung zum Induktionslöten von aus dünnwandigen Rohren bestehenden Rahmenkonstruktionen, insbesondere Zweiradrahmen |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
DK0463151T3 (da) | 1990-01-12 | 1996-07-01 | Cell Genesys Inc | Frembringelse af xenogene antistoffer |
US5476865A (en) * | 1994-07-06 | 1995-12-19 | Eli Lilly And Company | Methods of inhibiting bone loss |
CA2158822C (en) * | 1994-09-27 | 2008-12-23 | Kusuki Nishioka | Therapeutic agent for rheumatic disease |
CN1203922A (zh) * | 1997-03-21 | 1999-01-06 | 三共株式会社 | 人源化抗人fas抗体 |
AU734758B2 (en) * | 1997-04-01 | 2001-06-21 | Sankyo Company Limited | Anti-fas antibodies |
US6927044B2 (en) * | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
HUP0201333A3 (en) * | 1999-05-24 | 2004-11-29 | Sankyo Company Ltd Chuo Ku | Medicinal compositions containing anti-fas antibody |
DE10034607A1 (de) * | 2000-07-20 | 2002-02-07 | Gundram Jung | Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren |
US6600057B2 (en) * | 2000-12-29 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Matrix metalloproteinase inhibitors |
PE20030340A1 (es) * | 2001-08-28 | 2003-04-05 | Sankyo Co | Metodo para el tratamiento o prevencion de desgaste oseo |
TW200400830A (en) * | 2002-06-07 | 2004-01-16 | Sankyo Co | A pharmaceutical composition used in the treatment of bone erosion |
JP2004059582A (ja) * | 2002-06-07 | 2004-02-26 | Sankyo Co Ltd | 骨破壊の治療または予防剤組成物の併用効果 |
DE60332367D1 (de) | 2002-08-20 | 2010-06-10 | Astellas Pharma Inc | Hemmer des abbaus der extrazellulären matrix von arthrodia-knorpel |
JP2004277311A (ja) * | 2003-03-14 | 2004-10-07 | Wakunaga Pharmaceut Co Ltd | 新規mmp−3阻害剤 |
US20050014230A1 (en) | 2003-07-16 | 2005-01-20 | Ccl Holding Co., Ltd. | Preparation of fully human antibodies |
EP1498133A1 (en) | 2003-07-18 | 2005-01-19 | Aventis Pharma Deutschland GmbH | Use of a pak inhibitor for the treatment of a joint disease |
GB0327493D0 (en) | 2003-11-26 | 2003-12-31 | Univ Belfast | Treatment medicament |
WO2005053744A1 (en) * | 2003-11-26 | 2005-06-16 | Entelos, Inc. | TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR 1α ANTAGONISTS |
WO2005070126A2 (en) * | 2004-01-08 | 2005-08-04 | The Regents Of The University Of Colorado | Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors |
US7445794B1 (en) * | 2004-04-29 | 2008-11-04 | The Regents Of The University Of Colorado | Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors |
US7485468B2 (en) | 2004-10-15 | 2009-02-03 | Galapagos Bv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
JP2006151843A (ja) | 2004-11-26 | 2006-06-15 | Shimada Kagaku Kogyo Kk | カテプシンk阻害剤およびその機能が付与された食品 |
JP2007000141A (ja) | 2005-05-25 | 2007-01-11 | Tokyo Univ Of Science | 完全ヒト抗体産生ハイブリドーマの作製方法、及び融合ミエローマ細胞 |
JP4875865B2 (ja) | 2005-08-17 | 2012-02-15 | 株式会社日本バリアフリー | 変形性関節症の予防及び治療用NTx値低減剤 |
RU2298410C1 (ru) * | 2005-09-12 | 2007-05-10 | ЗАО "РеМеТэкс" | Биотрансплантат и способ лечения ревматических и аутоиммунных заболеваний |
JP2007204398A (ja) * | 2006-01-31 | 2007-08-16 | Towa Corporation 株式会社 | 脂肪分解促進作用組成物、cAMP−PDE活性阻害作用組成物、ヘキソサミニダーゼ遊離抑制作用組成物、MMP−1活性阻害作用組成物、コラーゲン産生促進組成物、皮膚線維芽細胞増殖作用組成物、エストロゲン様作用組成物、テストステロン5α−リダクターゼ活性阻害作用組成物、抗老化作用組成物、育毛作用組成物、美白作用組成物および抗炎症作用組成物 |
-
2009
- 2009-07-31 CN CN200980138584.6A patent/CN102170905B/zh active Active
- 2009-07-31 BR BRPI0917554A patent/BRPI0917554A2/pt not_active IP Right Cessation
- 2009-07-31 JP JP2009548250A patent/JP4560822B2/ja not_active Expired - Fee Related
- 2009-07-31 US US13/056,730 patent/US8377444B2/en active Active
- 2009-07-31 RU RU2011107405/15A patent/RU2492871C2/ru active
- 2009-07-31 CN CN201510417168.7A patent/CN105169389A/zh active Pending
- 2009-07-31 EP EP09802743.6A patent/EP2322220B1/en active Active
- 2009-07-31 KR KR1020117004979A patent/KR101196514B1/ko active IP Right Grant
- 2009-07-31 WO PCT/JP2009/003668 patent/WO2010013498A1/ja active Application Filing
- 2009-07-31 CA CA2732715A patent/CA2732715C/en active Active
- 2009-07-31 AU AU2009277824A patent/AU2009277824B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR101196514B1 (ko) | 2012-11-01 |
KR20110094267A (ko) | 2011-08-23 |
EP2322220A1 (en) | 2011-05-18 |
CA2732715A1 (en) | 2010-02-04 |
AU2009277824A1 (en) | 2010-02-04 |
US8377444B2 (en) | 2013-02-19 |
CN105169389A (zh) | 2015-12-23 |
CN102170905A (zh) | 2011-08-31 |
EP2322220A4 (en) | 2012-08-29 |
CA2732715C (en) | 2015-04-07 |
WO2010013498A1 (ja) | 2010-02-04 |
AU2009277824B2 (en) | 2013-06-06 |
JPWO2010013498A1 (ja) | 2012-01-05 |
JP4560822B2 (ja) | 2010-10-13 |
RU2011107405A (ru) | 2012-09-10 |
RU2492871C2 (ru) | 2013-09-20 |
CN102170905B (zh) | 2016-08-03 |
US20110182915A1 (en) | 2011-07-28 |
EP2322220B1 (en) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0921237A2 (pt) | métodos e composições para o tratamento de distúrbios associados ao complemento | |
BRPI0815911A2 (pt) | aparelhos de segurança para barbear ou depilar com proteção aprimorada | |
BR112013013311A2 (pt) | agente terapêutico de indução de citotoxicidade | |
BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
BRPI0815588A2 (pt) | Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano | |
BRPI0819361A2 (pt) | Composição de tratamento de cabelos e agente de tratamento | |
BRPI0812209A2 (pt) | Partícula de liberação contendo agente de benefício | |
BRPI0907135A2 (pt) | Processos de tratamento de dor crônica | |
BRPI0910854A2 (pt) | métodos de tratamento | |
BRPI1007477A2 (pt) | método, e, composição de tratamento de poço | |
BRPI0810525A2 (pt) | Composições e métodos para a profilaxia e tratamento de dependência química | |
BRPI0906975A2 (pt) | Escova de dente para o tratamento e/ou detecção de micróbios | |
BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
GB0823480D0 (en) | Devices for the treatment of fluids | |
BRPI0919127A2 (pt) | métodos para tratamento de água | |
BR112012005247A2 (pt) | agente antifitoviral | |
DK2330887T3 (da) | Behandlingsindretning | |
BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
BRPI1013778A2 (pt) | "equipamento para tratamento por imersão." | |
BRPI0917554A2 (pt) | agente de tratamento ou agente de prevenção para oesteoartrite | |
BRPI0811870A2 (pt) | Tratamento e prevenção de influenza | |
BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
BR112014030159A2 (pt) | agente para tratamento de floculação. | |
BRPI0812932A2 (pt) | Composições e métodos de tratar câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2473 DE 29-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |